Kontoor Brands Announces Expanded Global Leadership Roles for Jenni Broyles and Joseph Alkire
'Jenni and Joe have earned these expanded roles through proven performance and strategic leadership, a testament to the depth of talent we are cultivating at Kontoor Brands,' said Kontoor's President, Chief Executive Officer and Chairman, Scott Baxter. 'This leadership team has the vision and expertise to guide Kontoor's strategic evolution as we expand our portfolio of brands, accelerate growth and continue to deliver long-term value for our shareholders.'
Broyles will assume leadership responsibility for all international and commercial operations for the Lee and Wrangler brands in the role of Executive Vice President, Chief Commercial Officer & Global Head of Brands, reporting to Kontoor's President, Chief Executive Officer and Chairman, Scott Baxter.
Alkire will assume leadership responsibility for Kontoor's supply chain operations in the role of Executive Vice President, Chief Financial Officer & Global Head of Operations, reporting to Kontoor's President, Chief Executive Officer and Chairman, Scott Baxter.
The Helly Hansen business will continue reporting to Scott Baxter.
Tom Waldron, Executive Vice President and Chief Operating Officer, will exit Kontoor Brands after a transition period that will conclude September 30.
'I want to recognize and express my gratitude to Tom for his more than six years of leadership at Kontoor as well as his time at our predecessor company,' said Baxter. 'Tom has played an important role in our company, and we wish him well in his future endeavors.'
About Kontoor Brands
Kontoor Brands, Inc. (NYSE: KTB) is a portfolio of three of the world's most iconic lifestyle, outdoor and workwear brands: Wrangler ®, Lee ® and Helly Hansen ®. Kontoor Brands is a purpose-led organization focused on leveraging its global platform, strategic sourcing model and best-in-class supply chain to drive brand growth and deliver long-term value for its stakeholders. For more information about Kontoor Brands, please visit www.KontoorBrands.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
What to Watch Ahead of Disney Q3 Earnings
Disney (NYSE:DIS) reports third-quarter results for fiscal 2025 before the market opens on August 6. Consensus estimates call for adjusted EPS of approximately $1.45 on revenue of $23.7 billion, implying modest 2% top-line growth YoY. The stock is up 4% year-to-date and trades roughly 7% below its 52-week high of $124.70. Investor attention will focus on direct-to-consumer (DTC) margins and subscriber momentum. In Q2, Disney's DTC segment generated $336 million in operating income, up from $47 million a year earlier and added 1.4 million Disney+ subscribers. Subscriber stability and continued margin expansion will be key focus areas, as investors assess whether Disney's cost discipline is translating into lasting DTC profitability. The Experiences segment (theme parks and cruises) continues to perform well. Q2 experiences operating income rose 8% YoY to $2.5 billion, with investors assessing whether gating capacity or rising costs could pressure margins in Q3. Investors may also listen for commentary on recent releases such as Snow White and Fantastic Four, as sentiment around Disney's film strategy has been mixed and studio margins remain under pressure. With forward guidance unchanged ($5.75 adjusted EPS full year) and streaming margins expected to contribute more in H2, Disney's Q3 commentary will be critical. Management will need to demonstrate both streaming discipline and theme park profitability to support the current valuation. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Pitney Bowes Inc. (PBI): A Bull Case Theory: A Bull Case Theory
We came across a bullish thesis on Pitney Bowes Inc. on by GoodHouse. In this article, we will summarize the bulls' thesis on PBI. Pitney Bowes Inc.'s share was trading at $11.53 as of August 4th. PBI's trailing and forward P/E were 14.06 and 9.00, respectively according to Yahoo Finance. A busy logistics center filled with trucks and planes, showing the scale of the companies operations. Pitney Bowes (NYSE: PBI) represents a rare opportunity in today's market: a near-monopoly business trading at roughly 5.4x free cash flow, with multiple catalysts to unlock value under the leadership of newly appointed CEO Kurt Wolf. Wolf, the company's largest shareholder and architect of its turnaround following a successful 2023 proxy fight, brings a proven capital allocation track record and has committed to prioritizing shareholder returns. After divesting its loss-making Global E-Commerce segment, Pitney Bowes now operates two core businesses: Presort and SendTech. Presort, which controls approximately 25% market share in mail sortation, generated $671 million in revenue and $217 million in EBITDA over the trailing twelve months, boasting strong margins despite being a low-growth business. The crown jewel is SendTech, a dominant equipment leasing, SaaS, and payments platform with 70% market share, producing $1.25 billion in revenue and $418 million in EBITDA at a 33.5% margin. SendTech's integrated payments arm, PB Bank, amplifies profitability with an 80%+ return on equity, fueled by low-cost customer deposits. The company expects $330–$370 million of free cash flow in 2025, or about $1.93 per share, implying an 18.6% levered FCF yield at current prices. Management plans to execute its full $150 million buyback authorization this year, with further repurchase capacity likely once leverage falls below 3.0x by Q2—earlier than anticipated. This disciplined capital allocation, combined with minimal competitive threats in a highly regulated market, creates significant upside potential. Even modest multiple expansion could drive shares toward $16–$19, while downside risk remains limited given Pitney Bowes' entrenched market position and recurring cash flow profile. Previously, we covered a bullish thesis on Pitney Bowes Inc. (PBI) by Unemployed Value Degen in March 2025, which highlighted activist involvement, restructuring benefits, and ambitious 2025 EBITDA targets. The company's stock price has appreciated by approximately 21% since our coverage. This is because restructuring and divestiture efforts strengthened its financials. GoodHouse shares a similar view but emphasizes Kurt Wolf's appointment as CEO and aggressive buybacks as key catalysts. Pitney Bowes Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 34 hedge fund portfolios held PBI at the end of the first quarter which was 34 in the previous quarter. While we acknowledge the potential of PBI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
25 minutes ago
- Business Wire
Rosen Law Firm Urges Novo Nordisk A/S (NYSE: NVO) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that an investor filed a class action lawsuit on behalf of purchasers and acquirers of Novo Nordisk A/S (NYSE: NVO) securities between May 7, 2025 and July 28, 2025, both dates inclusive (the 'Class Period'). Novo Nordisk is a pharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Novo Nordisk A/S (NYSE: NVO) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Novo Nordisk's growth potential. Notably, Novo Nordisk's asserted potential to capitalize on the compounded market greatly understated the potential impact of the personalization exception to the compounded GLP-1 exclusion and overstated the likelihood that such patients would switch to Novo Nordisk's branded alternatives. Further, defendants greatly overstated the potential GLP-1 market or otherwise, Novo's capability to penetrate said markets to achieve continued growth. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Novo Nordisk. Investors who want to serve as lead plaintiff for the class must file their motions with the court by September 30, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome.
